Announcements Trials

Browse Landscape

Status

Not yet recruiting 1

Sponsor Class

Study Type

Observational 1 Interventional 1

Sponsor

Cancer Type

Conditions

Parathyroid Neoplasms 1 Hyperparathyroidism, Primary 1

Interventions

Blood Specimen Collection 137 Surveys and Questionnaires 131 Specimen Handling 57 Observation 55 Radiotherapy 44 Interviews as Topic 35 Drug Therapy 31 Surgical Procedures, Operative 31 Biopsy 30 Data Collection 25 Magnetic Resonance Spectroscopy 25 Nivolumab 21 Watchful Waiting 20 Immune Checkpoint Inhibitors 19 Magnetic Resonance Imaging 17 Standard of Care 17 Therapeutics 17 Immunotherapy 16 palbociclib 14 trastuzumab deruxtecan 14 Liquid Biopsy 13 Restraint, Physical 13 Tomography, X-Ray Computed 13 Hematologic Tests 12 Radiosurgery 12 Focus Groups 11 Genetic Testing 11 darolutamide 11 enzalutamide 11 pembrolizumab 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Rubidium-82 × 1 year × Clear all

NCT07099404 2025-08-22

PARAGON

Montreal Heart Institute

Not yet recruiting

Parathyroid Neoplasms, Hyperparathyroidism, Primary

Data powered by HemOnc (CC BY 4.0) Colophon ⚡